Back to search
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 trials you may qualify forTo find the highest tolerable dose of IACS-6274 that can be given alone, in combination with bevacizumab and paclitaxel, or in combination with capivasertib to…
This phase I/II trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients…
This trial studies the role of the gut microbiome and effectiveness of a fecal transplant on medication-induced gastrointestinal (GI) complications in patients…
This study assesses how personal relationships (such as friendships, family relationships, or romantic partners) influence the physical activity (exercise) and…
This pilot phase I trial studies how well VX15/2503 (pepinemab) with or without ipilimumab and/or nivolumab work in treating participants with stage IIIB-D mela…
This phase II trial investigates how well biomarkers on PET/CT imaging drive early discontinuation of anti-PD-1 therapy in patients with stage IIIB-IV melanoma…